ARCHIVES

FDA Approves Gleevec In 73 Days, A Speed Record.

This article is from The Cancer Letter archive.

Vol. 27 No. 20 | May 18, 2001

Download PDF Visit The Full Archive

Related Articles

NIH Reauthorization Still Lingering, Bills ‘Tie Hands’ Of NCI Director

October 18, 1991

NCCN Publishes Anemia Guidelines

April 12, 2002

Senate Votes Down Attempt to Cut NCI Funds $100 Million

October 3, 1975

Early HER2 Positive Patients At Higher Risk of Recurrence

January 30, 2009

Talking Back: FDA Faces Challenges Over Avastin & Prostate Cancer Prevention

January 21, 2011

CT Screening for Lung Cancer Unproven; Limit Use to Trials, Chest Physicians Urge.

September 14, 2007